New wearable device could help brain surgeons remove tumors more completely
NCT ID NCT04780009
First seen Jun 09, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study tests a special pair of magnifying glasses (loupes) that help surgeons see glowing brain tumor tissue during surgery. The device uses a fluorescent dye to make tumor cells light up, so the surgeon can remove more of the tumor while sparing healthy brain. The trial will compare the loupes to a standard large microscope to see if they are just as accurate. Thirty adults with glioblastoma or anaplastic astrocytoma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC ASTROCYTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fluorescent imaging agent (likely 5-ALA or similar)
What this could lead to
If successful, this could provide a low-cost, portable tool to help surgeons remove more tumor tissue during brain surgery, potentially improving patient outcomes.
What could go wrong
This is a small early-stage study (30 participants) focused on accuracy, not survival. The device may not prove better than existing methods, and results may not apply to all brain tumor types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.